Status:
COMPLETED
Pharmacokinetics of Different CoQ10 Formulations
Lead Sponsor:
Factors Group of Nutritional Companies Inc.
Collaborating Sponsors:
Isura
Conditions:
Coenzyme Q10 Pharmacokinetics
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
The objective of this trial is to compare the bioavailability (AUC, Tmax, and Cmax) of different Coenzyme Q10 preparations in healthy adults. Pharmacokinetic parameters of orally ingested CoQ10 such a...
Eligibility Criteria
Inclusion
- Participants are required to meet the following criteria to be eligible for enrollment: male or female aged 21-65 years or older
- Participants must complete an online health questionnaire on their medical history (pregnancy must be excluded) upon study enrolment.
- Voluntary, written, informed consent to participate in the study.
Exclusion
- Unstable medical condition; use of any acute medications during study period.
- Use of Coumadin Warfarin; use of supplements containing Coenzyme Q10, including the intake of any other supplements within 2 weeks of the beginning of the study (except for vitamin D and calcium). The use of any supplements except for vitamin D and calcium, are prohibited for the duration of the study.
- History of serious acute or chronic diseases such as gastrointestinal disorders, liver-, kidney-, cardiovascular, or hematological disease or diabetes; or other diseases; intolerances or food allergies such as gluten (in terms of the standardized meals).
- Using any form of nicotine or tobacco; participation in another investigational study
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06151171
Start Date
March 1 2022
End Date
October 31 2022
Last Update
December 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISURA
Burnaby, British Columbia, Canada, V3N 4S9